Clinical Report: AI in Pathology Fails Without Pathologists

Overview

Enhance clarity on the specific contributions of pathologists in AI tool development.

Background

The integration of AI in pathology has the potential to enhance diagnostic accuracy and efficiency. However, the success of these technologies heavily relies on the expertise of pathologists, who provide critical insights into clinical workflows and diagnostic needs. Without their input, AI tools may fail to address real-world challenges faced in pathology.

Data Highlights

No numerical data or trial data were provided in the source material.

Key Findings

• Pathologists provide essential clinical expertise that bridges AI development and clinical application.
• Early digital pathology systems lacking pathologist input failed to meet basic diagnostic needs.
• Continuous collaboration between developers and pathologists is crucial for creating clinically relevant tools.
• Misconceptions about pathology being an exact science can hinder effective AI tool development.
• Multidisciplinary collaboration enhances the effectiveness and impact of computational pathology projects.
• Digital pathology adoption barriers hinder meaningful work in computational pathology.

Clinical Implications

Detail actionable steps for healthcare professionals to collaborate with pathologists.

Conclusion

The involvement of pathologists is critical for the successful development and implementation of AI in pathology, ensuring that these tools provide meaningful clinical value.

References

1. the pathologist, Can We Keep Diagnostic Autonomy in an AI World?, 2026 -- Can We Keep Diagnostic Autonomy in an AI World?
2. the pathologist, Beyond Image Analysis: How AI is Reshaping the Pathology Workflow, 2026 -- Beyond Image Analysis: How AI is Reshaping the Pathology Workflow
3. the pathologist, Five Strategies Against the AI Complacency Trap, 2026 -- Five Strategies Against the AI Complacency Trap
4. the pathologist, AI Tackles Pathology Report Complexity, 2026 -- AI Tackles Pathology Report Complexity
5. Royal College of Pathologists of Australasia, AI-in-Pathology Guidelines, 2026 -- Artificial Intelligence in Pathology
6. Polish Society of Pathologists, Guidelines for the adoption of digital pathology, 2026 -- Guidelines for the adoption of digital pathology in clinical pathology units
7. CAP, At CAP25, Pathologists and AI Leaders Join Forces, 2026 -- At CAP25, Pathologists and AI Leaders Join Forces to Shape the Future of Diagnostics
8. FDA, Marketing Submission Recommendations for AI-Enabled Devices, 2025 -- Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions
9. https://www.rcpa.edu.au/Library/College-Policies/Guidelines/Artificial-Intelligence-in-Pathology
10. Guidelines for the adoption of digital pathology in clinical pathology units recommended by the polish society of pathologists | Diagnostic Pathology | Springer Nature Link
11. At CAP25, Pathologists and AI Leaders Join Forces to Shape the Future of Diagnostics
12. Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions | FDA
13. Artificial intelligence in histopathology and cytopathology: an umbrella review of systematic reviews and meta-analyses | Surgical and Experimental Pathology | Springer Nature Link
14. External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE platform protocol - PubMed
15. FDA grants 510(k) clearance to AI-powered prostate cancer diagnostic | Urology Times
16. validating whole slide imaging for diagnostic purposes in pathology: guideline update summary of recommendations